Hyperhomocysteinemia induced by feeding rats diets rich in DL-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure.

[1]  M. Eberlin,et al.  Increased endothelin‐1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia , 2009, British journal of pharmacology.

[2]  L. Papatheodorou,et al.  Vascular oxidant stress and inflammation in hyperhomocysteinemia. , 2007, Antioxidants & redox signaling.

[3]  M. Eberlin,et al.  Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. , 2006, European journal of pharmacology.

[4]  A. M. de Oliveira,et al.  Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB‐induced relaxation , 2005, British journal of pharmacology.

[5]  B. Foeger,et al.  Hepatic lipase polymorphism and increased risk of peripheral arterial disease , 2005, Journal of internal medicine.

[6]  P. Vanhoutte,et al.  Chronic Mild Hyperhomocysteinemia Induces Aortic Endothelial Dysfunction but Does Not Elevate Arterial Pressure in Rats , 2005, Journal of Vascular Research.

[7]  L. Masnatta,et al.  Mild hyperhomocysteinemia promotes renal hemodynamic dysfunction without histopathologic changes in adult rats. , 2004, Kidney international.

[8]  A. M. de Oliveira,et al.  The balloon catheter induces an increase in contralateral carotid artery reactivity to angiotensin II and phenylephrine , 2004, British journal of pharmacology.

[9]  M. Eberlin,et al.  Chronic Methionine Load-Induced Hyperhomocysteinemia Enhances Rat Carotid Responsiveness for Angiotensin II , 2004, Pharmacology.

[10]  G. Leoncini,et al.  Effects of homocysteine on l‐arginine transport and nitric oxide formation in human platelets , 2003, European journal of clinical investigation.

[11]  James M. Roberts,et al.  Changes in markers of vascular injury in response to transient hyperhomocysteinemia. , 2003, Metabolism: clinical and experimental.

[12]  C. H. Hill,et al.  Fibrillin-2 defects impair elastic fiber assembly in a homocysteinemic chick model. , 2002, The Journal of nutrition.

[13]  G. Renier,et al.  Homocysteine induces protein kinase C activation and stimulates c-Fos and lipoprotein lipase expression in macrophages. , 2002, Diabetes.

[14]  I. Rosenberg,et al.  Homocysteine and its disulfide derivatives: a suggested consensus terminology. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Lewis,et al.  Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Z. Ungvari,et al.  Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[17]  R. Man,et al.  Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. , 1998, Biochimica et biophysica acta.

[18]  A. Majors,et al.  Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Dalton,et al.  Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c‐fos and c‐myb in smooth muscle cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  B. Nordestgaard.  The vascular endothelial barrier — selective retention of lipoproteins , 1996, Current opinion in lipidology.

[21]  B. Jones,et al.  Homocysteine mediated endothelial cell toxicity and its amelioration. , 1996, Atherosclerosis.

[22]  R. Alexander.  Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.

[23]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Ueland,et al.  Clinical significance of pharmacological modulation of homocysteine metabolism. , 1990, Trends in pharmacological sciences.

[25]  K. Mccully,et al.  Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide. , 1990, Atherosclerosis.

[26]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Mccully,et al.  Homocysteine thiolactone, N-homocysteine thiolactonyl retinamide, and platelet aggregation. , 1987, Research communications in chemical pathology and pharmacology.

[28]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[29]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[30]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[31]  G. Striker,et al.  Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. , 1980, Thrombosis research.

[32]  R. Ross,et al.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. , 1976, The Journal of clinical investigation.

[33]  K. Mccully.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. , 1969, The American journal of pathology.

[34]  A. M. de Oliveira,et al.  Total stenosis triggers compensatory responsiveness of carotid and basilar arteries to endothelin-1 and phenylephrine. , 2008, Pharmacological research.

[35]  J. Davignon,et al.  Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. , 2003, The Journal of laboratory and clinical medicine.

[36]  T. Lüscher,et al.  Endothelial dysfunction in coronary artery disease. , 1993, Annual review of medicine.

[37]  R. Ross,et al.  Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. , 1993, British heart journal.

[38]  G. Rubanyi,et al.  The role of endothelium in cardiovascular homeostasis and diseases. , 1993, Journal of cardiovascular pharmacology.

[39]  M. Malinow,et al.  Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. , 1992, Annual review of nutrition.

[40]  K. Mccully,et al.  Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. , 1989, Atherosclerosis.